Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Licensing opportunity from NIH: HIV-1 integrase inhibitors

April 28, 2000

EMEA issues warning and modified labeling for Viramune

April 26, 2000

Anti-HIV activity demonstrated for natural product used in Japan for hepatitis

April 24, 2000

BioQuest and Biovector Therapeutics to collaborate on HIV vaccine

April 24, 2000

Initial clinical results with HE-2000 indicate immune system switch in HIV

April 20, 2000

Warner-Lambert describes potent new anti-HIV agents with improved pharmacokinetics

April 19, 2000

Novel approach to cell-targeted therapy of HIV designed by Lepetit

April 18, 2000

Clinical hold placed on South African study of Coviracil

April 12, 2000

Sultams prove to be potent NNRTIs in biological screens; work presented at ACS meeting

April 10, 2000

Progenics reports HIV therapy progress at Keystone symposium

April 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Other news to note for July 27, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbvie, Genmab, Merck, Par, Thyora.